pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
afatinib dimaleate
Gilotrif (afatinib dimaleate)
Non-Small Cell Lung Cancer
Boehringer Ingelheim Corp
0 catalysts
Phase 2
afimetoran
Systemic Lupus Erythematosus
Toll-like receptor 7Toll-like receptor 8
Beeline Medicines Corp
0 catalysts
Phase 3
afimkibart
Crohn's Disease (Regional Enteritis)
F. Hoffmann-La Roche Ltd
catalysts
← prev
page 181 of 271
next →
131
Pain89
Neurology1
0
Phase 3
afuresertib hydrochloride
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Laekna Inc
0 catalysts
Marketed
agalsidase beta
Fabrazyme (agalsidase beta)
Fabry Disease
Genzyme Corp
0 catalysts
Phase 3
aglatimagene besadenovec
ProstAtak (aglatimagene besadenovec)
Prostate Cancer
$CADLCandel Therapeutics, Inc.
0 catalysts
Phase 2
agomelatine
agomelatine [INN]
Major Depressive Disorder
$ANROAlto Neuroscience, Inc.
0 catalysts
Phase 2
aguracingene cadoparvovec
Achromatopsia
$MGTXMeiraGTx Holdings plc
0 catalysts
Marketed
albendazole
Albendazole (albendazole)
Echinococcosis (Hydatid Disease)
Novadoz Pharmaceuticals LLC
0 catalysts
Marketed
albumin (human)
Human Albumin (albumin (human))
Hypovolemia (Hypovolaemia)
Octapharma USA Inc
0 catalysts
Phase 3
albumin (recombinant) (human)
Hypoalbuminemia
Wuhan Healthgen Biotechnology Corp
0 catalysts
Marketed
albutrepenonacog alfa LA
Idelvion (albutrepenonacog alfa [INN])
Hemophilia B (Factor IX Deficiency)
CSL Behring LLC
0 catalysts
Phase 2
albuvirtide LA
Human Immunodeficiency Virus (HIV) Infections (AIDS)
GP41
Frontier Biotechnologies Inc
0 catalysts
Marketed
alcaftadine
Alcaftadine (alcaftadine)
Allergic Conjunctivitis
Fosun Pharma USA Inc
0 catalysts
Marketed
alclometasone dipropionate
Alclometasone Dipropionate (alclometasone dipropionate)
Atopic Dermatitis (Atopic Eczema)
Fougera Pharmaceuticals Inc
0 catalysts
Marketed
aldesleukin
Proleukin (aldesleukin)
Metastatic Renal Cell Carcinoma
$IOVAIOVANCE BIOTHERAPEUTICS, INC.
0 catalysts
Phase 3
aldoxorubicin
Metastatic Pancreatic Cancer
DNA topoisomerase 2-alpha
LadRx Corp
0 catalysts
Marketed
alectinib
Alecensa (alectinib)
Non-Small Cell Lung Cancer
F. Hoffmann-La Roche Ltd
0 catalysts
Marketed
alemtuzumab
Campath (alemtuzumab)
B-Cell Chronic Lymphocytic Leukemia
Genzyme Corp
0 catalysts
Phase 2
aleniglipron l-arginine
Overweight
$GPCRStructure Therapeutics Inc.
0 catalysts
Marketed
alfuzosin hydrochloride ER
Uroxatral (alfuzosin hydrochloride)
Storage Symptoms of Benign Prostatic Hyperplasia
Concordia Healthcare USA Inc
0 catalysts
Preclinical
alidornase alfa
alidornase alfa [INN]
Pulmonary Sarcoidosis
Sarcomed AB
0 catalysts
Phase 2
alintegimod
alintegimod [INN]
Colorectal Cancer
7 Hills Pharma LLC
0 catalysts
Phase 2
alisertib
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Aurora kinase A
$PBYIPUMA BIOTECHNOLOGY, INC.
0 catalysts
Marketed
aliskiren fumarate
Aliskiren Fumarate Prasco (aliskiren fumarate)
Hypertension
Prasco LLC
0 catalysts
Phase 3
alixorexton
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
$ALKSAlkermes plc.
0 catalysts
Phase 3
allantoin
Zorblisa (allantoin)
Epidermolysis Bullosa
Paradigm Therapeutics Inc
0 catalysts
Marketed
allopurinol
Zyloprim (allopurinol)
Kidney Disease (Nephropathy)
Casper Pharma LLC
0 catalysts
Marketed
almotriptan malate
Almotriptan (almotriptan malate)
Migraine
Ajanta Pharma USA Inc
0 catalysts
Phase 2
alnodesertib
alnodesertib [INN]
Metastatic Colorectal Cancer
Artios Pharma Ltd
0 catalysts